# A Clinical Study on the Use of a Domestically Produced Three-dimensional Cardiac Electrophysiological Mapping System Combined With Pressure Monitoring Technology and Star Mapping Technology for the Treatment of Paroxysmal Atrial Fibrillation.

> **NCT07039032** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai MicroPort EP MedTech Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Paroxysmal Atrial Fibrillation (PAF)

## Interventions

- **DEVICE:** FireMagic™ Magbot Ablation Catheter 、FireMagic™ TrueForce™ Ablation Catheter

## Key facts

- **NCT ID:** NCT07039032
- **Lead sponsor:** Shanghai MicroPort EP MedTech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-30
- **Primary completion:** 2025-09-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07039032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07039032, "A Clinical Study on the Use of a Domestically Produced Three-dimensional Cardiac Electrophysiological Mapping System Combined With Pressure Monitoring Technology and Star Mapping Technology for the Treatment of Paroxysmal Atrial Fibrillation.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07039032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*